Exports In 2022, Denmark exported $2.06B in Vaccines, blood, antisera, toxins and cultures, making it the 17th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 5th most exported product in Denmark. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Denmark are: United States ($304M), Germany ($234M), Netherlands ($149M), Italy ($99M), and Japan ($98M).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Denmark between 2021 and 2022 were Italy ($72.1M), Germany ($58.5M), and Angola ($54.5M).
Imports In 2022, Denmark imported $1.49B in Vaccines, blood, antisera, toxins and cultures, becoming the 28th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 9th most imported product in Denmark. Denmark imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($484M), Belgium ($241M), Switzerland ($124M), United States ($99.5M), and Austria ($86.3M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Denmark between 2021 and 2022 were Germany ($66.8M), Spain ($35.2M), and Poland ($22.1M).